RegMedNet is part of Taylor & Francis Group.
Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.
Follow us on social media
Sign up for our RegMedNet weekly news round-up
Factors that influence trust in non-standard stem cell therapies among patients with...
Comparative study of the effects of subcutaneously administered umbilical cord-derived mesenchymal stem...
Clinical applications of induced pluripotent stem cell-mediated therapies in cancer: progress, challenges,...
Reimbursement routes and past practices for advanced therapy medicinal products in the...
Three-dimensional bio-printed microtissues: precision medicine approach in primary liver cancer
Comparison of 3D culture systems on mesenchymal stem cell longevity, regenerative potential,...